Adipogenic differentiation of adiposederived stem cells in 3-dimensional spheroid cultures (microtissue): Implications for the reconstructive surgeon

Journal of Plastic, Reconstructive and Aesthetic Surgery

Volumn 67, Issue 12, 2014, Pages 1726-1734

  Naderi, Naghmeh ^a,b   Wilde, Charlotte ^a   Haque, Tasmia ^a   Francis, Wendy ^a   Seifalian, Alexander M ^b   Thornton, Catherine A ^a   Xia, Zhidao ^a   Whitaker, Iain S ^a  

^a SWANSEA UNIVERSITY   (United Kingdom)

^b UNIVERSITY COLLEGE LONDON   (United Kingdom)

Author keywords

Adipose differentiation; Adipose tissue regeneration; ADSC; Flow cytometry; In vitro; Microtissue

Indexed keywords

CD14 ANTIGEN; CD19 ANTIGEN; CD34 ANTIGEN; CD45 ANTIGEN; ENDOGLIN; FLUORESCENT DYE; THY 1 ANTIGEN; AZO COMPOUND; COLORING AGENT; LEUKOCYTE ANTIGEN; OIL RED O;

ABDOMINAL FAT; ADIPOCYTE; ADIPOGENESIS; ADIPOSE DERIVED STEM CELL; ADIPOSE TISSUE; ADULT; ARTICLE; CELL DENSITY; CELL ISOLATION; CELL POPULATION; CELL VIABILITY; CLINICAL ARTICLE; CONTROLLED STUDY; FLOW CYTOMETRY; HUMAN; IN VITRO STUDY; MICROTISSUE; PRIORITY JOURNAL; SPHEROID CELL; SURGEON; TISSUE CULTURE; TISSUE DIFFERENTIATION; CELL CULTURE; CELL DIFFERENTIATION; CHEMISTRY; CYTOLOGY; MULTICELLULAR SPHEROID; PHYSIOLOGY; PLASTIC SURGERY; REGENERATION; STEM CELL; TISSUE CULTURE TECHNIQUE; TISSUE SCAFFOLD;

ADIPOCYTES; ANTIGENS, CD; AZO COMPOUNDS; CELL DIFFERENTIATION; CELLS, CULTURED; COLORING AGENTS; FLOW CYTOMETRY; HUMANS; RECONSTRUCTIVE SURGICAL PROCEDURES; REGENERATION; SPHEROIDS, CELLULAR; STEM CELLS; TISSUE CULTURE TECHNIQUES; TISSUE SCAFFOLDS;

EID: 84925552341     PISSN: 17486815     EISSN: 18780539     Source Type: Journal    
DOI: 10.1016/j.bjps.2014.08.013     Document Type: Article

References (46)

1. Katz AJ, Llull R, Hedrick MH, Futrell JW. Emerging approaches to the tissue engineering of fat. Clin Plast Surg 1999;26(4):587-603. viii.
2. Sterodimas A, De Faria J, Correa WE, Pitanguy I. Tissue engineering in plastic surgery: an up-to-date review of the current literature. Ann Plast Surg 2009;62(1):97-103.
3. Barret JP, Sarobe N, Grande N, Vila D, Palacin JM. Maximizing results for lipofilling in facial reconstruction. Clin Plast Surg 2009;36(3):487-92.
4. Khouri RK, Eisenmann-Klein M, Cardoso E, et al. Brava and autologous fat transfer is a safe and effective breast augmentation alternative: results of a 6-year, 81-patient, prospective multicenter study. Plast Reconstr Surg 2012;129(5):1173-87.
5. Derder M, Whitaker IS, Boudana D, et al. The use of lipofilling to treat congenital hypoplastic breast anomalies: preliminary experiences. Ann Plast Surg 2013 [Epub ahead of print].
6. Cherubino M, Rubin JP, Miljkovic N, Kelmendi-Doko A, Marra KG. Adipose-derived stem cells for wound healing applications. Ann Plast Surg 2011;66(2):210-5.
7. Forcheron F, Agay D, Scherthan H, et al. Autologous adipocyte derived stem cells favour healing in a minipig model of cutaneous radiation syndrome. PLoS One 2012;7(2):e31694.
8. Sultan SM, Barr JS, Butala P, et al. Fat grafting accelerates revascularisation and decreases fibrosis following thermal injury. J Plast Reconstr Aesthet Surg 2012;65(2):219-27.
9. Eaves 3rd FF, Haeck PC, Rohrich RJ. ASAPS/ASPS position statement on stem cells and fat grafting. Plast Reconstr Surg 2012;129(1):285-7.
10. Topcu A, Aydin OE, Ünlü M, Barutcu A, Atabey A. Increasing the viability of fat grafts by vascular endothelial growth factor. Arch Facial Plast Surg 2012;14(4):270-6.
11. Boschert MT, Beckert BW, Puckett CL, Concannon MJ. Analysis of lipocyte viability after liposuction. Plast Reconstr Surg 2002;109(2):761-5. discussion 766-7.
12. Hyakusoku H, Ogawa R, Ono S, Ishii N, Hirakawa K. Complications after autologous fat injection to the breast. Plast Reconstr Surg 2009;123(1):360-70. discussion 371-2.
13. Butala P, Hazen A, Szpalski C, Sultan SM, Coleman SR, Warren SM. Endogenous stem cell therapy enhances fat graft survival. Plast Reconstr Surg 2012;130(2):293-306.
14. Lam SM, Glasgold RA, Glasgold MJ. Limitations, complications, and long-term sequelae of fat transfer. Facial Plast Surg Clin North Am 2008;16(4):391-9. v.
15. Eto H, Kato H, Suga H, et al. The fate of adipocytes after nonvascularized fat grafting: evidence of early death and replacement of adipocytes. Plast Reconstr Surg 2012;129(5):1081-92.
16. Zuk PA, Zhu M, Mizuno H, et al. Multilineage cells from human adipose tissue: implications for cell-based therapies. Tissue Eng 2001;7(2):211-28.
17. Zuk PA. The adipose-derived stem cell: looking back and looking ahead. Mol Biol Cell 2010;21(11):1783-7.
18. Watson D, Keller GS, Lacombe V, Fodor PB, Rawnsley J, Lask GP. Autologous fibroblasts for treatment of facial rhytids and dermal depressions. A pilot study. Arch Facial Plast Surg 1999;1(3):165-70.
19. Mizuno H. Adipose-derived stem cells for tissue repair and regeneration: ten years of research and a literature review. J Nihon Med Sch 2009;76(2):56-66.
20. Gronthos S, Franklin DM, Leddy HA, Robey PG, Storms RW, Gimble JM. Surface protein characterization of human adipose tissue-derived stromal cells. J Cell Physiol 2001;189(1):54-63.
21. De Ugarte DA, Morizono K, Elbarbary A, et al. Comparison of multi-lineage cells from human adipose tissue and bone marrow. Cells Tissues Organs 2003;174(3):101-9.
22. Wagner W, Wein F, Seckinger A, et al. Comparative characteristics of mesenchymal stem cells from human bone marrow, adipose tissue, and umbilical cord blood. Exp Hematol 2005;33(11):1402-16.
23. Kern S, Eichler H, Stoeve J, Klüter H, Bieback K. Comparative analysis of mesenchymal stem cells from bone marrow, umbilical cord blood, or adipose tissue. Stem Cells 2006;24(5):1294-301.
24. Zuk PA, Zhu M, Ashjian P, et al. Human adipose tissue is a source of multipotent stem cells. Mol Biol Cell 2002;13(12):4279-95.
25. Gimble JM, Guilak F. Differentiation potential of adipose derived adult stem (ADAS) cells. Curr Top Dev Biol 2003;58:137-60.
26. Fraser JK, Wulur I, Alfonso Z, Hedrick MH. Fat tissue: an underappreciated source of stem cells for biotechnology. Trends Biotechnol 2006;24(4):150-4.
27. Gimble JM, Katz AJ, Bunnell BA. Adipose-derived stem cells for regenerative medicine. Circ Res 2007;100(9):1249-60.
28. Lequeux C, Oni G. Adipose derived stem cells: efficiency, toxicity, stability of BrdU labeling and effects on self-renewal and adipose differentiation. Mol Cell Biochem 2011;351(1-2):65-75.
29. Lindroos B, Suuronen R, Miettinen S. The potential of adipose stem cells in regenerative medicine. Stem Cell Rev Rep 2011;7(2):269-91.
30. Kelm JM, Fussenegger M. Scaffold-free cell delivery for use in regenerative medicine. Adv Drug Deliv Rev 2010;62(7-8):753-64.
31. Langenbach F, et al. Scaffold-free microtissues: differences from monolayer cultures and their potential in bone tissue engineering. Clin Oral Investig 2012;347(3):701-11.
32. Palmiero C, et al. Engineered dermal equivalent tissue in vitro by assembly of microtissue precursors. Acta Biomater 2010;6(7):2548-53.
33. Kelm JM, et al. A novel concept for scaffold-free vessel tissue engineering: self-assembly of microtissue building blocks. J Biotechnol 2010;148(1):46-55.
34. Meyer U, et al. Cartilage defect regeneration by ex vivo engineered autologous microtissueepreliminary results. In Vivo 2012;26(2):251-7.
35. Kelm JM, Fussenegger M. Microscale tissue engineering using gravity-enforced cell assembly. Trends Biotechnol 2004;22(4):195-202.
36. Dromard C, et al. Human adipose derived stroma/stem cells grow in serum-free medium as floating spheres. Exp Cell Res 2011;317(6):770-80.
37. Hildner F, et al. How chondrogenic are human umbilical cord matrix cells? A comparison to adipose-derived stem cells. J Tissue Eng Regen Med 2010;4(3):242-5.
38. Lin K, et al. Characterization of adipose tissue-derived cells isolated with the celution system. Cytotherapy 2008;10(4):417-26.
39. Griesche N, et al. A simple modification of the separation method reduces heterogeneity of adipose-derived stem cells. Cells Tissues Organs 2010;192(2):106-15.
40. Baptista LS, et al. An alternative method for the isolation of mesenchymal stromal cells derived from lipoaspirate samples. Cytotherapy 2009;11(6):706-15.
41. Pilgaard L, et al. Comparative analysis of highly defined proteases for the isolation of adipose tissue-derived stem cells. Regen Med 2008;3(5):705-15.
42. da Silva Meirelles L, Chagastelles PC, Nardi NB. Mesenchymal stem cells reside in virtually all post-natal organs and tissues. J Cell Sci 2006;119(Pt 11):2204-13.
43. Maumus M, et al. Native human adipose stromal cells: localization, morphology and phenotype. Int J Obes (Lond) 2011;35(9):1141-53.
44. Planat-Benard V, et al. Plasticity of human adipose lineage cells toward endothelial cells: physiological and therapeutic perspectives. Circulation 2004;109(5):656-63.
45. Suga H, et al. Rapid expansion of human adipose-derived stromal cells preserving multipotency. Cytotherapy 2007;9(8):738-45.
46. Amos PJ, et al. Human adipose-derived stromal cells accelerate diabetic wound healing: impact of cell formulation and delivery. Tissue Eng Part A 2010;16(5):1595-606.